The Korea Exchange KOSDAQ Market Division announced on the 4th that it will extend the deadline for holding the Corporate Review Committee to decide on the approval of Ostem Implant's voluntary delisting.


The Exchange explained, "Considering that the stock consolidation process is currently underway, the deadline for holding the Corporate Review Committee will be extended by 15 business days." Previously, Ostem Implant submitted a voluntary delisting application to the Exchange on the 28th of last month. The Exchange must hold the Corporate Review Committee within 15 business days from the date of receipt of the application.



The Exchange stated, "We plan to provide information regarding the approval of Ostem Implant's voluntary delisting by August 9."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing